product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
IKKε Antibody
catalog :
2690
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
reactivity :
human, mouse, rat
application :
western blot, immunohistochemistry - paraffin section, immunohistochemistry - frozen section, immunohistochemistry knockout validation
citations: 2
Published Application/Species/Sample/DilutionReference
  • western blot; human; 1:1000; loading ...; fig 2b
  • immunohistochemistry knockout validation; mouse; 1:200; loading ...; fig 2h
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig 4e
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 2d
He S, Nian F, Chen W, Yin L, Auchoybur M, Tao Z, et al. I-κB kinase-ε knockout protects against angiotensin II induced aortic valve thickening in apolipoprotein E deficient mice. Biomed Pharmacother. 2019;109:1287-1295 pubmed publisher
Zhu M, Wang M, Yang F, Tian Y, Cai J, Yang H, et al. miR-155-5p inhibition promotes the transition of bone marrow mesenchymal stem cells to gastric cancer tissue derived MSC-like cells via NF-κB p65 activation. Oncotarget. 2016;7:16567-80 pubmed publisher
product information
SKU :
2690S
Product-Name :
IKKε Antibody
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R
Applications :
Western blot
Product-Category :
Immunology and Inflammation
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
80
Host :
Rabbit
Target :
IKK-epsilon
Primary-Protein :
IKK-epsilon
Alt-Names :
I-kappa-B kinase epsilon,IKBKE,IKK-E,IKK-epsilon,IKK-i,IKK-related kinase epsilon,IKKE,IKKI,Inducible I kappa-B kinase,Inhibitor of nuclear factor kappa-B kinase subunit epsilon,KIAA0151,MGC125294,MGC125295,MGC125297,inducible IkappaB kinase,inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.